Phyto-oestrogen excretion and rate of bone loss in postmenopausal women

European Journal of Clinical Nutrition

Volumn 52, Issue 11, 1998, Pages 850-855

  Kardinaal, A F M ^a   Morton, M S ^b   Bruggemann Rotgans I E M ^a   Van Beresteijn, E C H ^c  

^a TNO   (Netherlands)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c NIZO FOOD RESEARCH   (Netherlands)

Author keywords

Bone density; Menopause; Oestrogens; Osteoporosis; Urinary isoflavones; Urinary lignans

Indexed keywords

CALCIUM; DAIDZEIN; ENTEROLACTONE; EQUOL; GENISTEIN; ISOFLAVONE DERIVATIVE; LIGNAN; PHYTOESTROGEN; VEGETABLE PROTEIN;

ADULT; AGE; ARTICLE; BODY MASS; BONE ATROPHY; BONE DENSITY; CALCIUM INTAKE; CLINICAL ARTICLE; CORTICAL BONE; DIETARY FIBER; DIETARY INTAKE; FEMALE; FOLLOW UP; GAS CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; POSTMENOPAUSE; PROTEIN INTAKE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; URINARY EXCRETION;

EID: 0031790653     PISSN: 09543007     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1600659     Document Type: Article

References (35)

1. Adami S, Bufalino L, Cervetti R, Di Marco C, Di Munno O, Fantasia GC, Semi U, Vecchiet L & Passeri M (1997): Ipriflavone prevents radial bone loss in postmenopausal women with low hone mass over 2 years. Osteoporos: Int. 7, 119-125.
2. Adlercreutz H (1995): Phytoestrogens: epidemiology and a possible role in cancer protection. Environ. Health Perspect. 103, Suppl.7, 103-112.
3. Adlercreutz H & Mazur W (1997): Phyto-oestrogens and Western diseases. Ann. Med. 29, 95-120.
4. Agnusdei D, Gennari C & Bufalino L (1995): Prevention of early postmenopausal bone loss using low doses of conjugated estrogens and the non-hormonal, bone-active drug ipriflavone. Osteoporos. Int. 5, 462-466.
5. Agnusdei D, Crepaldi G, Isaia G, Mazzuoli G, Ortolani S, Passeri M, Bufalino L & Gennari C (1997): A double-blind. placebo-controlled trial of ipriflavone for prevention of postmenopausal spinal bone loss. Calcif. Tissue Int. 61, 142-147.
6. Albertazzi P, Pansini F, Bonaccorsi G, Zanotti L, Forini E & De Aloysio D (1998): The effect of dietary soy supplementation on hot flushes. Obstet. Gynecol. 91, 6-11.
7. Anderson JJ, Ambrose WW & Garner SC (1995): Orally dosed genistein from soy and prevention of cancellous bone loss in two ovariectomized rat models. J. Nutr. 125, Suppl., 799S (abstract).
8. Andersen JJB, Garner SC, Ambrose WW & Ohue T (1996): Genistein and bone: studies in rat models and bone cell lines. Second International Symposium on the Role of Soy in Preventing and Treating Chronic Disease, 1996, Brussels (abstract).
9. Anonymous (1993): Zo eet Nederland, 1992; resultaten van de Voedselcon-sumptiepeiling 1992. Den Haag: Voorlichtingsbureau voor de Voeding.
10. Anthony MS, Clarkson TB, Hughes CL, Morgan TM & Burke GL (1996): Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J. Nutr. 126, 43-50.
11. Arjmandi BH, Alekel L, Hollis BW, Amin D, Stacewicz-Sapuntzakis M, Guo P & Kukreja SC (1996): Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J. Nutr. 126, 161-167.
12. Beresteijn ECH van, Hof MA, van't Waard H de, Dekker PR, Neeter R, Winkeldermaat HJ, Visser RM, Schaafsma G, Schaik M van & Duursma SA (1986): Design and data quality of a mixed longitudinal study to elucidate the role of dietary calcium and phosphorus on bone mineralization in pre-, peri-, and postmenopausal women. Am. J. Clin. Nutr. 43, 538-548.
13. Beresteijn ECH van, van 't Hof MA, van der Heiden-Winkeldermaat JH, ten Have Witjes A & Neeter R (1987): Evaluation of the usefulness of the cross-check dietary history method in longitudinal studies, J. Chron. Dis. 40, 1051-1058.
14. Beresteijn ECH van, van 't Hof MA, Schaafsma G, de Waard H & Duursma SA (1990): Habitual dietary calcium intake and cortical bone loss in perimenopausal women: a longitudinal study. Calcif. Tissue Int. 47, 338-344.
15. Blair HC (1996): Action of genistein and other tyrosine kinase inhibitors in preventing osteoporosis. Second international Symposium on the Role of Soy in Preventing and Treating Chronic Disease, 1996, Brussels (abstract).
16. Brzezinski A, Adlercreutz H, Shaoul R, Rösler A, Shmueli A, Tanos V & Schenker JG (1997): Short-term effect of phyto-estrogen-rich diet on postmenopausal women. Menopause 4, 89-94.
17. Collaborative Group on Hormonal Factors in Breast Cancer (1997): Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancer 350, 1047- 1059.
18. Cooper C & Barrett-Connor E (1996): Epidemiology of osteoporosis. In Osteoporosis 1996, Proceedings of the 1996 World Congress on Osteoporosis, Amsterdam, 1996, ed. SE Papapoulos, et al, pp 75-77. Amsterdam: Elsevier.
19. Coward L, Barnes NC, Setchell KDR & Barnes S (1993): Genistein, daidzein, and their beta-glycoside conjugates - antitumor isoflavones in soybean foods from American and Asian diets. J. Agr. Food Chem. 41, 1961-1967.
20. de Aloysio D, Gambacciani M, Altieri P, Ciaponi M, Ventura V, Mura M, Genazzani AR & Bottiglioni F (1997): Bone density changes in postmenopausal women with the administration of ipriflavone alone or in association with low-dose ERT. Gynecol. Endocrinol. 11, 289-293.
21. Brdman JW, Stillman RJ, Lee KF & Potter SM (1996): Short-term effects of soybean isoflavones on bone in postmenopausal women. Second International Symposium on the Role of Soy in Preventing and Treating Chronic Disease, 1996, Brussels (abstract).
22. Fanti O, Faugere MC, Gang Z, Schmidt J, Cohen D & Malluche HH (1996): Systematic administraton of genistein partially prevents bone loss in ovariectomized rats in a non-oestrogen-like mechanism. Second International Symposium on the Role of Soy in Preventing and Treating Chronic Disease, 1996, Brussels (abstract).
23. Fukutake M, Takahashi M, Ishida K, Kawamura H, Sugimura T & Wakabayashi K (1996): Quantification of genistein and genistin in soybeans and soybean products. Food Chem. Toxicol. 34, 457-461.
24. Gambacciani M, Ciaponi M, Cappagli B, Piaggesi L & Genazzani AR (1997): Effects of combined low dose of isoflavone derivative ipriflavone and estrogen replacement on bone mineral density and metabolism in postmenopausal women. Maturitas 28, 75-81.
25. Gennari C, Adami S, Agnusdei D, Bufalino L, Cervetti R, Crepaldi G, Di Marco C, Di Munno O, Fantasia L, Isaia GC, Mazzuoli GF, Ortolani S, Passeri M, Semi U & Vecchiet L (1997): Effect of chronic treatment with ipriflavone in postmenopausal women with low bone mass. Calcif. Tissue Int. 61. Suppl.1, S19-22.
26. Ingram D, Sanders K, Kolybaba M & Lopez D (1997): Case-control study of phyto-oestrogens and breast cancer. Lancet 350, 990-994.
27. Karr SC, Lampe JW, Hutchins AM & Slavin JL (1997): Urinary isoflavonoid excretion in humans is dose dependent at low to moderate levels of soy-protein consumption. Am. J. Clin. Nutr. 66, 46-51.
28. Melton III LJ (1996): Global aspects of osteoporosis epidemiology. In Osteoporosis 1996. Proceedings of the 1996 World Congress on Osteoporosis, Amsterdam, 1996. ed. SE Papapoulos, et al, pp 79-86. Amsterdam: Elsevier.
29. Morton MS, Wilcox G, Wahlqvist ML & Griffiths K (1994): Determination of lignans and isoflavonoids in human female plasma following dietary supplementation. J. Endocrinol. 142, 251-259.
30. Murkies AL, Wilcox G & Davis SR (1998): Clinical review 92: phytoestrogens. J. Clin. Endocrinol. Metab. 83, 297-303.
31. Ravnikar V (1987): Compliance with hormone therapy. Am. J. Obstet. Gynecol. 156, 1332-1334.
32. Recker RR (1993): Current therapy for osteoporosis. J. Clin. Endocrinol. Metab. 76, 14-16.
33. Setchell KDR, Borriello SP, Hulme P, Kirk DN & Axelson M (1984): Nonsteroidal estrogens of dietary origin: possible role in hormone-dependent disease. Am. J. Clin. Nutr. 40, 569-578.
34. Thompson LU, Robb P, Serraino M & Cheung F (1991): Mammalian lignan production from various foods. Nutr. Cancer 16, 43-52.
35. Valente M, Bufalino L, Castiglione GN, D'Angelo R, Mancuso A, Galoppi P & Zichella L (1994): Effects of 1-year treatment with ipriflavone on bone in postmenopausal women with low bone mass. Calcif. Tissue Int. 5, 377-380.